Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Soluble urokinase plasminogen activator receptor level is an independent predictor of the presence and severity of coronary artery disease and of future adverse events.
Eapen DJ, Manocha P, Ghasemzadeh N, Patel RS, Al Kassem H, Hammadah M, Veledar E, Le NA, Pielak T, Thorball CW, Velegraki A, Kremastinos DT, Lerakis S, Sperling L, Quyyumi AA. Eapen DJ, et al. Among authors: al kassem h. J Am Heart Assoc. 2014 Oct 23;3(5):e001118. doi: 10.1161/JAHA.114.001118. J Am Heart Assoc. 2014. PMID: 25341887 Free PMC article.
Plasma stromal cell-derived factor 1α/CXCL12 level predicts long-term adverse cardiovascular outcomes in patients with coronary artery disease.
Ghasemzadeh N, Hritani AW, De Staercke C, Eapen DJ, Veledar E, Al Kassem H, Khayata M, Zafari AM, Sperling L, Hooper C, Vaccarino V, Mavromatis K, Quyyumi AA. Ghasemzadeh N, et al. Among authors: al kassem h. Atherosclerosis. 2015 Jan;238(1):113-8. doi: 10.1016/j.atherosclerosis.2014.10.094. Epub 2014 Oct 29. Atherosclerosis. 2015. PMID: 25461737 Free PMC article.
Plasma soluble urokinase-type plasminogen activator receptor level is independently associated with coronary microvascular function in patients with non-obstructive coronary artery disease.
Mekonnen G, Corban MT, Hung OY, Eshtehardi P, Eapen DJ, Al-Kassem H, Rasoul-Arzrumly E, Gogas BD, McDaniel MC, Pielak T, Thorball CW, Sperling L, Quyyumi AA, Samady H. Mekonnen G, et al. Among authors: al kassem h. Atherosclerosis. 2015 Mar;239(1):55-60. doi: 10.1016/j.atherosclerosis.2014.12.025. Epub 2014 Dec 20. Atherosclerosis. 2015. PMID: 25574858
Elevated Levels of Serum Fibrin and Fibrinogen Degradation Products Are Independent Predictors of Larger Coronary Plaques and Greater Plaque Necrotic Core.
Corban MT, Hung OY, Mekonnen G, Eshtehardi P, Eapen DJ, Rasoul-Arzrumly E, Al Kassem H, Manocha P, Ko YA, Sperling LS, Quyyumi AA, Samady H. Corban MT, et al. Among authors: al kassem h. Circ J. 2016;80(4):931-7. doi: 10.1253/circj.CJ-15-0768. Epub 2016 Feb 25. Circ J. 2016. PMID: 26911453 Free PMC article. Clinical Trial.
Pathway-Specific Aggregate Biomarker Risk Score Is Associated With Burden of Coronary Artery Disease and Predicts Near-Term Risk of Myocardial Infarction and Death.
Ghasemzedah N, Hayek SS, Ko YA, Eapen DJ, Patel RS, Manocha P, Al Kassem H, Khayata M, Veledar E, Kremastinos D, Thorball CW, Pielak T, Sikora S, Zafari AM, Lerakis S, Sperling L, Vaccarino V, Epstein SE, Quyyumi AA. Ghasemzedah N, et al. Among authors: al kassem h. Circ Cardiovasc Qual Outcomes. 2017 Mar;10(3):e001493. doi: 10.1161/CIRCOUTCOMES.115.001493. Circ Cardiovasc Qual Outcomes. 2017. PMID: 28280039 Free PMC article.